Sensus Healthcare Q1 revenues $8.3M, net loss $2.6M vs. net income $2.3M year ago; forecasts profitability rest of year

Sensus Healthcare, Inc.

2025-Q1 EPS reported -$0.16 revenue$8,344,000

Revenue $8.3M, down 22% YoY from $10.7M; net loss $0.16 per share vs. net income $0.14 per diluted share.
Gross margin 53.0% vs. 62.6% year ago due to lower sales and higher service costs.
Shipped 21 SRT systems, including 15 to a large customer; treatment volume from FDAs increased 65% sequentially.
Management expects profitability in each of next three quarters and full year; affirms 3-5 additional multisite FDA customers this year.
R&D expense $2.6M vs. $0.9M driven by lobbying costs for billing code reimbursement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.